Filing Details
- Accession Number:
- 0001123292-16-002802
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-04 19:35:06
- Reporting Period:
- 2016-10-01
- Filing Date:
- 2016-10-04
- Accepted Time:
- 2016-10-04 19:35:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640688 | T Santosh Varghese | C/O Vivus, Inc. 351 E. Evelyn Avenue Mountain View CA 94041 | Chief Medical Officer | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-10-01 | 356 | $1.14 | 88,610 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-10-01 | 354 | $1.14 | 88,256 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Sold to pay the tax liability resulting from the vesting of 925 restricted stock units granted on January 28, 2014.
- Sold to pay the tax liability resulting from the vesting of 919 restricted stock units granted on January 23, 2015.